Novavax (NVAX, $13.01) was a top loser yesterday, declining to $13.01 per share. Of the 903 stocks analyzed in the Biotechnology Industry, of them () exhibited an Uptrend while of them () were in a Downtrend. 378 similar cases when NVAX's price dropped within one day were found. In out of those 378 cases, NVAX's price went down during the subsequent month. Based on these historical data, the odds of a Downtrend continuation for NVAX are